ClinicalTrials.Veeva

Menu

The Prevalence of Fibromyalgia in Adults at Al-Karak Jordan a Cross-sectional Study

M

Mutah University

Status

Enrolling

Conditions

Orthopedic Disorder
Fibromyalgia

Treatments

Other: Cross sectional

Study type

Observational

Funder types

Other

Identifiers

NCT06103058
20235012

Details and patient eligibility

About

Fibromyalgia is a chronic and intricate musculoskeletal disorder characterized by widespread pain, fatigue, and tenderness in specific anatomical regions. Although its prevalence varies among populations, understanding the prevalence in different geographical areas is crucial for healthcare planning. This cross-sectional study aims to determine the prevalence of fibromyalgia in adults residing in Al-Karak, Jordan. The city's unique demographic and environmental characteristics may influence the occurrence of fibromyalgia among its adult population. The study aims to address gaps in knowledge, provide localized insights, and shed light on fibromyalgia's burden on the community's health. Accurate prevalence data aids healthcare planning and resource allocation.

Enrollment

965 estimated patients

Sex

All

Ages

1 month to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Using google forms, this cross-sectional study was carried out, and the participants were reached via social media platforms (5)

. Participants' autonomy was maintained, and no direct benefit was gained in return for filling out the questionnaire. The ethics committee at the Faculty of Medicine, Mutah University, Karak, Jordan, provided the required ethical approval prior to the initiation of this study. Moreover, the committee ensured that the study was designed according to the principles of the Declaration of Helsinki (Date: 13 February 2023. Reference number: 992023). In this study, the authors targeted Karak government citizens, in Jordan. Accordingly, the required sample size to achieve a 99% Confidence interval was 663 participants.

Trial design

965 participants in 2 patient groups

Positive for fibromyalgia
Description:
26.5% prevalence of fibromyalgia
Negative for fibromyalgia
Description:
26.5% prevalence of fibromyalgia
Treatment:
Other: Cross sectional

Trial contacts and locations

1

Loading...

Central trial contact

Mohammad Abu-Jeyyab, MD; Alaa Akel, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems